GSA Capital Partners’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,071
| Closed | -$77K | – | 1619 |
|
|
2024
Q1 | $77K | Sell |
19,071
-130,807
| -87% | -$528K | 0.01% | 1508 |
|
|
2023
Q4 | $457K | Sell |
149,878
-128,408
| -46% | -$392K | 0.04% | 856 |
|
|
2023
Q3 | $835K | Buy |
278,286
+82,208
| +42% | +$247K | 0.07% | 500 |
|
|
2023
Q2 | $733K | Buy |
196,078
+52,908
| +37% | +$198K | 0.07% | 494 |
|
|
2023
Q1 | $480K | Buy |
143,170
+86,250
| +152% | +$289K | 0.05% | 743 |
|
|
2022
Q4 | $274K | Buy |
+56,920
| New | +$274K | 0.03% | 995 |
|
|
2022
Q3 | – | Sell |
-25,080
| Closed | -$178K | – | 1505 |
|
|
2022
Q2 | $178K | Buy |
+25,080
| New | +$178K | 0.03% | 1100 |
|